CClinicalTrials.gg
CompletedNCT03681626Updated Jun 4, 2026

Does Tracheal Suction During Extubation in Intensive Care Unit Decrease Functional Residual Capacity

An observational study in Critically Ill, Extubation and Intensive Care Unit, sponsored by University Hospital, Rouen. Completed at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-04.

Sponsored by University Hospital, Rouen · Observational

Study type
Observational
Enrollment
60
Ages
18 Years and older
Sex
All
01

Study summary

Little is known about the procedure of extubation of patients admitted in Intensive Care Units (ICU). In particular, effects of tracheal suction during extubation have never been evaluated. Tracheal suction induces alveolar derecruitment in sedated patients under mechanical ventilation and is a major source of pain.

The aim of this study was to evaluate the impact of tracheal suction during the extubation procedure of critically ill patients on the end-expiratory lung volume.

Read the detailed description

This is a prospective, monocentric study, conducted in the surgical ICU of the university hospital of Rouen, France.

Sixty patients were expected to be randomized before extubation into two groups (ratio of 1:1) with different extubation protocols depending on whether tracheal suction was performed or not.

After oral information and collection of the non opposition of the patient to participate in the study, eligible patients were randomized (raio 1:1) in two groups: "tracheal suction" group or "no tracheal suction" group.

The allocation concealment was assured by enclosing assignments in sequentially numbered, opaque, sealed envelopes. Envelopes were opened after enrolment of each patient by the medical doctor in charged. Each envelope contained a number by a random allocation process using a computer-generated random block design (the randomization list was established by the local biostatistics unit before the beginning of the study).

Juste after inclusion, the 30 minutes standardized extubation protocol started and consisted of:

  • arterial blood gas analysis before the extubation (if there wasn't one dating less than 6 hours),
  • adjustment of the backrest of the bed in tilt to + 45 °,
  • tracheal suction 30 minutes before extubation (using a 14 french catheter, a vacuum of -200 mmHg systematically measured by a manometer XX),
  • the ventilator was then set on pressure support ventilation with pressure support level of 8 cmH2O and positive end-expiratory pressure (PEEP) of 5 cmH2O (FiO2 was adjusted for oxygen saturation by pulse oximetry between 95 and 98%) for 30 minutes,
  • installation of electrode belt for electrical impedance tomography (EIT) monitoring (Pulmovista 500, Dräger®) and calibration of the system,
  • aspiration of oropharyngeal secretions immediately before extubation with an oral cannula.
  • for "tracheal suction" group, extubation occured 30 minutes after inclusion. A tracheal suction (using a 14 french catheter, a vacuum of -200 mmHg) was performed at the same time as removal of the tracheal tube, after disconnection of the ventilator and after deflating the balloon of the tracheal tube.
  • for "no tracheal suction" group, extubation occured 30 minutes after inclusion and was performed after deflation of the balloon (and without further maneuver).
  • all patients underwent chest physical therapy between the 15th and 60th minutes following extubation.

No calculation of the number of subjects needed was possible (no data available concerning ΔEELI at extubation).

Data were described in the whole population and for each group ("tracheal suction" and "no tracheal suction") using the usual descriptive parameters: frequency for qualitative variables, median and interquartile range (IQR) for quantitative variables. Statistical analysis consisted of a nonparametric Mann and Whitney test for the quantitative variables and an exact Fisher test for the qualitative variables (using Statistical Analysis System software, version 9.4, Statistical Analysis System Institute; Cary, NC). The significance of the tests was retained for an α risk of 5%.

02

Conditions studied

  • Critically Ill
  • Extubation
  • Intensive Care Unit

Browse trials for

Keywords

  • critically ill patient
  • extubation
  • tracheal suction
  • intensive care unit
03

In context

Critical Illness

1,881 studies on the registry are indexed under Critical Illness; 462 are open to participants now.

This study's enrollment of 60 is below the median of 130 across 867 observational studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

University Hospital, Rouen is the lead sponsor of 410 studies on the registry; 104 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • age of 18 years or more
  • hospitalization in the surgical ICU (whatever the cause of hospitalization)
  • under mechanical ventilation via a tracheal tube (oro or nasotracheal) for at least 24 hours
  • satisfying general criteria for mechanical ventilation weaning (described by the French Language Resuscitation Society)
  • having successfully completed a spontaneous breathing trial (among those described by the SRLF)
  • physiotherapist available during the first hour after extubation

Exclusion criteria

Exclusion Criteria:

  • the presence of an electrical implantable medical device (pacemaker, automatic defibrillator, deep brain stimulation box)
  • body mass index (BMI) > 50
  • pregnancy
  • tracheal tube with subglottic suction channel
  • technical impossibility of monitoring by electrical impedance tomography (chest plaster, undrained pneumothorax, ...).
05

Study design

Enrollment
60 participants (actual)
Patient registry
No

Groups and cohorts

  • tracheal suction

    After a standardized protocol during the thirty minutes before extubation, extubation was performed with a standardized tracheal suction.

    Procedure: tracheal suction

  • no tracheal suction

    After a standardized protocol during the thirty minutes before extubation, extubation was performed without tracheal suction.

    Procedure: no tracheal suction

Interventions

  • Procedureno tracheal suction

    No tracheal suctioning during extubation

  • Proceduretracheal suction

    tracheal suctioning during extubation

06

What researchers measure

Primary outcomes

  1. ΔEELI 15

    The primary endpoint was the end-expiratory lung impedance variation (ΔEELI) between immediately before extubation and 15 minutes after extubation (ΔEELI 15). It happened so 45 minutes after inclusion (30 minutes of extubation protocol and 15 minutes after extubation)

    Time frame: 15 minutes after extubation

Secondary outcomes

  1. ΔEELI H1

    The end-expiratory lung impedance variation (ΔEELI) between immediately before extubation and 60 minutes after extubation

    Time frame: 60 minutes after extubation

  2. ΔEELI H2

    The end-expiratory lung impedance variation (ΔEELI) between immediately before extubation and 120 minutes after extubation

    Time frame: 120 minutes after extubation

  3. Lowest oxygen saturation by pulse oximetry

    The lowest oxygen saturation by pulse oximetry observed within 6 hours after extubation

    Time frame: 360 minutes after extubation

  4. Oxygen flow

    The maximum oxygen flow administered within 6 hours after extubation (for oxygen saturation by pulse oximetry between 95 and 98%)

    Time frame: 360 minutes after extubation

  5. arterial partial pressure of oxygen

    Variation of arterial partial pressure of oxygen within 6 hours after extubation (1 arterial blood gas analysis before extubation and 2 after)

    Time frame: 360 minutes after extubation

  6. arterial oxygen saturation

    Variation of arterial oxygen saturation within 6 hours after extubation (1 arterial blood gas analysis before extubation and 2 after)

    Time frame: 360 minutes after extubation

  7. arterial partial pressure of carbon dioxide

    Variation of arterial partial pressure of carbon dioxide within 6 hours after extubation (1 arterial blood gas analysis before extubation and 2 after)

    Time frame: 360 minutes after extubation

  8. Respiratory rates

    Respiratory rates 1 hour and then, 6 hours after the extubation

    Time frame: 360 minutes after extubation

  9. Respiratory complication

    Composite endpoint including the occurence of at least of of the following complication during 48 hours after extubation: * failure of extubation (need for reintubation) * new atelectasis after extubation (a chest x-ray was supposed to support the diagnosis) * the use of non-invasive ventilation for acute respiratory distress * new pneumonia after extubation

    Time frame: 48 hours after extubation

  10. Death

    The occurence of death of the patient during 48 hours after extubation (whatever the cause of death was)

    Time frame: 48 hours after extubation

07

Study locations

1 site
  • CHU de ROUEN
    Rouen, 76031, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03681626
Lead sponsor
University Hospital, Rouen
Responsible party
Sponsor
First posted
Sep 24, 2018
Start date
Oct 27, 2015
Primary completion
Aug 31, 2016
Completion
Sep 2, 2016
Last update
Jun 4, 2026

Study contacts

Benoît VEBER, MD, PhD
study chair

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion